Wang Zuo-peng

Abstract CT132: Orelabrutinib, a potent and selective Bruton's tyrosine kinase inhibitor with superior safety profile and excellent PK/PD properties

S. Shakib, Renbin Zhao, Bin Zhang, 2020, Tumor Biology.